Helicobacter pylori infection and gastric cancer: Systematic review of the epidemiological studies

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 7, 1999, Pages 851-856

  Danesh, J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ADULT; ARTICLE; CANCER INCIDENCE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK; SEROEPIDEMIOLOGY; STOMACH CANCER;

EPIDEMIOLOGIC STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ODDS RATIO; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; STOMACH NEOPLASMS;

EID: 0033041345     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00546.x     Document Type: Article

References (65)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273.
2. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504.
3. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9(Suppl. 2): 33-9.
4. Goodwin CS, Mendall MM, Northfield TC. Helicobacter pylori infection. Lancet 1997; 349: 265-9.
5. NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
6. IARC Working Group. Monographs on the evaluation of the carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori. IARC Publications, Geneva, 1994, 177-241.
7. Webb PM, Forman D. Helicobacter pylori as a risk factor for cancer. Balliere's Clin Gastroenterol 1996; 9: 563-82.
8. Crespi M, Citarda F. Helicobacter pylori and gastric cancer: an overrated risk? Scand J Gastroenterol 1996; 31: 1041-6.
9. Archimandritis A, Bitsakas J, Tjivras M, et al. Non-cardia gastric adenocarcinoma and Helicobacter pylori infection. Ital J Gastroenterol 1993; 25: 368-71.
10. Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994; 73: 2691-4.
11. Asaka M, Kato M, Kudo M, et al. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol Hepatol 1995; 7(Suppl. 1): S7-10.
12. Kikuchi S, Wada O, Nakajima T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995; 75: 2789-93.
13. Li D, Gao X, Guan H. Relationship between Helicobacter pylori infection and diffuse and intestinal types of stomach cancer. Chung Hua Liu 1995; 16: 299-302.
14. Estevens J, Fidalgo P, Tendeiro T, et al. Anti-Helicobacter pylori antibodies: prevalence and gastric adenocarcinoma in Portugal: report of a case-control study. Eur J Cancer Prev 1993; 2: 377-80.
15. Miglio F, Miglioli M, Holton J, et al. Prevalence of Helicobacter pylori in patients with gastric carcinoma. Irish J Med Sci 1992; 161(Suppl. 10): GCE 37(Abstract).
16. Kang HC, Chung IS. Helicobacter pylori infection and gastric adenocarcinoma in Korea: prevalence and distribution of H. pylori in resected specimen of gastric cancer. J Cath Med Coll 1992; 45: 849-63.
17. Menegatti M, Vaira D, Miglioli M, et al. Helicobacter pylori in patients with gastric and nongastric cancer. Am J Gastroenterol 1995; 90: 1278-81.
18. Kurtenkov O, Klaamas K, Cavacci A, Wadstrom T. IgG immune response to a recombinant fragment of cagA in patients with gastric cancer: relation to the ABO(h) blood group phenotype and the stage of cancer. Gut 1997; 41(Suppl. 1): A48(Abstract).
19. Lin JT, Wang JT, Wu MS, Huang SC, Wang TH. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics. Hepatogastroenterology 1993; 40: 600-3.
20. Hansson LE, Engstrand L, Nyren O, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098-103.
21. Talley NJ, Zinsmeister AR, Weaver A, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-9.
22. Rudi J, Muller M, von Herbay A, et al. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand J Gastroenterol 1995; 30: 958-63.
23. Rudi J, Kolb C, Maiwald M, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997; 42: 1652-9.
24. Barreto-Zuniga R, Maruyama M, Kato Y, et al. Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serological and histological studies. J Gastroenterol 1997; 32: 289-94.
25. Sipponen P, Kosunen TU, Valle J, Rihela M, Seppala K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992; 45: 319-23.
26. Blaser MJ, Kobayashi K, Cover TL, Cao P, Feurer ID, Perez-Perez GI. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer 1993; 55: 799-802.
27. Fukuda H, Saito D, Hayashi S, et al. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 1995; 86: 64-71.
28. Chira C, Rovinaru I, Pop F, Raducan L, Copaci I, Vadan R. Gastric cancer and Helicobacter pylori infection. Gut 1996; 39(Suppl. 3): A68(Abstract).
29. Kuipers EJ, Gracia-Casanova M, Pena AS, et al. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol 1993; 28: 433-7.
30. Kato S, Onda M, Matsukura N, et al. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. Cancer 1996; 77: 1654-61.
31. Ng TM, Fock KM, Khim MM, et al. Gastric cancer and H. pylori infection in Singapore: lack of association with cagA status. Gut 1997; 41(Suppl. 1): A47(Abstract).
32. Lin JT, Wang JT, Wang TH, Wu MS, Lee TK, Chen CJ. Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. Scand J Gastroenterol 1993; 28: 1067-72.
33. Igarashi H, Takahashi S, Ishiyama N, et al. Is Helicobacter pylori a causal agent in gastric carcinoma? Irish J Med Sci 1992; 161(Suppl. 10): GCE 36(Abstract).
34. Fiocca R, Luinetti O, Villani L, et al. High incidence of Helicobacter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis. Eur J Gastroenterol Hepatol 1993; 5(Suppl. 2): S2-8.
35. Loffeld RJFL, Willems I, Flendrig JA, Arends JW. Helicobacter pylori and gastric carcinoma. Hispathology 1990; 17: 537-41.
36. Kokkola A, Valle J, Haapainen R, Sipponen P, Kivilaakso E, Puolakkainen P. Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol 1996; 31: 643-7.
37. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type adenocarcinomas. J Natl Cancer Inst 1991; 83: 640-3.
38. Boixeda D, Gisbdert JP, Arocena C, Baleriola I, Martin de Argila C, Garcia Plaza A. Prevalencia de la infeccion por Helicobacter pylori en el adenocarcinoma gastrico y en la gastritis cronica. Rev Esp Enf Digest 1996; 88: 403-8.
39. Craanen ME, Blok P, Dekker W, Tytgat GN. Helicobacter pylori and early gastric cancer. Gut 1994; 35: 1372-4.
40. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A. High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 1997; 32: 465-8.
41. Tokumaru K, Kojima T, Satoh K, et al. CagA gene of Helicobacter pylori is a not a carcinogenic marker in Japanese patients. Gut 1997; 41(Suppl. 1): A47(Abstract).
42. Kim HY, Cho BD, Chang WK, et al. Helicobacter pylori infection and the risk of gastric cancer among the Korean population. J Gastroenterol Hepatol 1997; 12: 100-3.
43. Webb PM, Yu MC, Forman D, et al. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996; 67: 603-7.
44. Aromaa A, Kosunen TU, Knekt P, et al. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996; 144: 142-9.
45. Lin JT, Wang LY, Wang JT, Wang TH, Yang CS, Chen CJ. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer in a cohort of 9775 men in Taiwan. Anticancer Res 1995; 15: 603-6.
46. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302-5.
47. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori and mortality from ischaemic heart disease: a negative result from a large prospective study. Br Med J 1997; 315: 1199-201.
48. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
49. Hansen S, Vollset SE, Melby K, Jellum E. Strong association of previous Helicobacter pylori infection to distal gastric adenocarcinoma. Am J Gastroenterol 1994; 89: A1358(Abstract).
50. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GJ, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
51. Siman JH, Forsgren A, Floren CH. Association between Helicobacter pylori and gastric carcinoma in the city of Malmo, Sweden - a prospective study. Gut 1997; 41(Suppl. 1): A45(Abstract).
52. Watanabe Y, Kurata JH, Mizuno S, et al. Helicobacter pylori infection and gastric cancer: a nested case-control study in a rural area of Japan. Dig Dis Sci 1998; 42: 1383-7.
53. Tulinius H, Ogmundsdottir H, Kristinsson KG, Tryggvadottir L, Jonasson I, Sigfusson N. A retrospective case-control study of H. pylori infection and subsequent gastric cancer in Iceland. IACR Annual Meeting, November 1997, abstract.
54. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroentorol 1996; 91: 1785-8.
55. Huang JQ, Sridhar S, Chen Y, Hunt R. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169-79.
56. Easterbrook P, Berlin J, Gopalan R, Matthews D. Publication bias in clinical research. Lancet 1991; 337: 867-72.
57. Feldman RA, Evans SJW. Accuracy of diagnostic methods used for epidemiological studies of Helicobacter pylori. Aliment Pharmacol Ther 1995; 9(Suppl. 2): 21-31.
58. Rosenstock SJ, Andersen LP, Bonnevie O, Jorgensen T. Sero-conversion and sero-reversion in IgG antibodies to H. pylori: an 11-year follow-up of 2,523 randomly selected Danes. Gut 1996; 39(Suppl. 3): A3(Abstract.).
59. Munoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol, Biomarkers Prevention 1994; 3: 445-51.
60. Blaser MJ, Perez-Perez GI, Kleanthous H. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-15.
61. Forman D. Lessons from ongoing intervention studies. In: Hunt R, Tytgat G, eds. Helicobacter pylori: Basic Mechanisms to Clinical Cure. Amsterdam: Kluwer Academic Publishers, 1998.
62. Danesh J, Forman D, Collins R, Peto R. Helicobacter pylori screening and gastric cancer. Lancet 1996; 348: 758-9.
63. Peto R. General reflections on principles and purposes: indirect and direct purposes of the present monograph. In: Junshi C, Campbell TC, Junyao L, Peto R, eds. Diet, Life-Style and Mortality in China: a Study of the Characteristics of 65 Chinese Counties. Oxford: Oxford University Press, 1990: 72-8.
64. Swerdlow AJ, Dos Santos Silva I, Reid A, Qiao Z, Brewster DH, Arrundale J. Trends in cancer incidence and mortality in Scotland. Br J Cancer 1998; 77(Suppl. 3): 1-16.
65. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1-27.